DrugPatentWatch Database Preview
Mylan Asi Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for MYLAN ASI, and what generic and branded alternatives to MYLAN ASI drugs are available?
MYLAN ASI has nineteen approved drugs.
Summary for Mylan Asi
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 14 |
| NDAs: | 19 |
Drugs and US Patents for Mylan Asi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Asi | MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE | midazolam hydrochloride | INJECTABLE;INJECTION | 090315-001 | Nov 29, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Asi | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 090318-004 | Sep 23, 2014 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Asi | LORAZEPAM | lorazepam | INJECTABLE;INJECTION | 200217-002 | Apr 4, 2017 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Asi | SUMATRIPTAN SUCCINATE | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 090641-001 | Jul 28, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
